te Boekhorst PA - Search Results

1

Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.

Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ. Adriaansen HJ, et al. Among authors: te boekhorst pa. Blood. 1993 Jun 1;81(11):3043-51. Blood. 1993. PMID: 8098967 Free article.

2

Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.

te Boekhorst PA, Löwenberg B, van Kapel J, Nooter K, Sonneveld P. te Boekhorst PA, et al. Leukemia. 1995 Jun;9(6):1025-31. Leukemia. 1995. PMID: 7541095

3

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.

te Boekhorst PA, de Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Löwenberg B, Sonneveld P. te Boekhorst PA, et al. Blood. 1993 Nov 15;82(10):3157-62. Blood. 1993. PMID: 7693039 Free article.

4

Patchy hematopoiesis mimicking bone metastasis.

Cornelisse AC, Te Boekhorst PAW. Cornelisse AC, et al. Blood. 2018 Oct 11;132(15):1626. doi: 10.1182/blood-2018-06-856823. Blood. 2018. PMID: 30309877 Free article. No abstract available.

5

Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.

te Boekhorst PA, Löwenberg B, Sonneveld P. te Boekhorst PA, et al. Leukemia. 1994 Sep;8(9):1480-6. Leukemia. 1994. PMID: 7522289

6

Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.

te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. te Boekhorst PA, et al. Leukemia. 1993 Aug;7(8):1191-8. Leukemia. 1993. PMID: 7688839

7

Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.

te Boekhorst PA, Löwenberg B, Sonneveld P. te Boekhorst PA, et al. Leukemia. 1993 Oct;7(10):1637-44. Leukemia. 1993. PMID: 7692194

8

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: te boekhorst pa. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

9

Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial.

van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, Te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs JH. van der Meer PF, et al. Blood. 2018 Jul 12;132(2):223-231. doi: 10.1182/blood-2018-02-831289. Epub 2018 May 17. Blood. 2018. PMID: 29773572 Free article.

10

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.

Bouillon AS, Ventura Ferreira MS, Awad SA, Richter J, Hochhaus A, Kunzmann V, Dengler J, Janssen J, Ossenkoppele G, Westerweel PE, Te Boekhorst PAW, Mahon FX, Hjorth-Hansen H, Isfort S, Fioretos T, Hummel S, Schemionek M, Wilop S, Koschmieder S, Saußele S, Mustjoki S, Beier F, Brümmendorf TH. Bouillon AS, et al. Blood Adv. 2018 Jul 10;2(13):1572-1579. doi: 10.1182/bloodadvances.2018017772. Blood Adv. 2018. PMID: 29980572 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page